Invesco Ltd (IVZ) is currently showing bearish momentum, with the stock recently crossing below its 200-day moving average, a key technical indicator. The stock is trading at $15.27 as of the latest data, with a 52-week range of $14.16 to $19.55. The Relative Strength Index (RSI) for IVZ is at 20.64 (RSI_6), 27.16 (RSI_12), and 29.15 (RSI_14), all of which are below 30, indicating oversold conditions. The Stochastic Oscillator is also in oversold territory, with values of 12.58 for %K and 11.74 for %D. The MACD is negative at -0.56, with a bearish signal line.
The stock is approaching its lower Bollinger Band, which could act as a support level. The Fibonacci support levels are at $14.92 (S1) and $13.89 (S3), while resistance levels are at $17.62 (R1) and $19.29 (R3). The pivot point is at $16.59.
Recent news indicates improving fundamentals for IVZ, with its rating increasing from 71% to 83% based on David Dreman's contrarian strategy, suggesting growing interest in the stock. However, the stock has been under pressure, with a 2.30% decline in regular market trading. The launch of managed futures ETFs by Invesco could be a positive catalyst, but the broader market sentiment remains bearish.
Given the oversold conditions and approaching support levels, IVZ may experience a slight rebound in the next trading week. However, the overall bearish trend suggests limited upside. Based on technical indicators and news sentiment, the stock is expected to trade between $15.50 and $16.50 next week.
Recommendation: Buy IVZ at the current price of $15.27, with a target price of $16.50. Consider setting a stop-loss at $14.92 to limit potential losses.
The price of IVZ is predicted to go up 15.4%, based on the high correlation periods with QVCC. The similarity of these two price pattern on the periods is 96.73%.
IVZ
QVCC
With $1.663 trillion in AUM at the end of March 2024, Invesco is in the second-largest tier of U.S.-based asset managers, which includes firms like Pimco and Capital Group.
Invesco's balanced fund operations had 78% and 92% of its actively managed assets outperforming peers on a three- and five-year basis, respectively, at the end of the fourth quarter of 2023.
The firm's fixed-income funds have also held up well, with 76% and 85% of actively managed bond fund assets outperforming peers on a three- and five-year basis, respectively, at the end of December 2023.
Barclays
2025-01-17
Price Target
$19 → $18
Upside
+4.65%
Morgan Stanley
2024-12-20
Price Target
$18 → $19
Upside
+9.64%
Deutsche Bank
2024-11-11
Price Target
$18 → $19
Upside
+3.88%